TABLE 5.

Comparison of IPSS, Qmax, and PVR at 1 year of follow‐up between groups of patients according to grade group after holmium laser enucleation of the prostate.

	Overall	BPH	Low‐risk PCa	High‐risk PCa	Overall p‐value
IPSS a	0 [0–3]	1 [0–3]	0 [0–1.5]	5 [0–8]	0.129
Qmax b	19 [12.7–29.7]	18.8 [12.7–30]	19.7 [12.7–22.9]	20 d	0.625
PVR c	15 [0–38]	15 [0–38]	16 [3–36]	13 d	0.961

Note: Median [interquartile range 25th to 75th].

Abbreviations: BPH, benign prostatic hyperplasia; IPSS, International Prostate Symptom Score; PCa, prostate cancer; PVR, post‐void residual volume; Qmax, maximum urinary flow rate.

^a One hundred forty‐two patients were analysed.

^b One hundred seventy‐six patients were analysed.

^c One hundred eighty‐five patients were analysed.

^d Only median is reported due to the limited number of patients.